A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
Titel:
A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
Auteur:
Hong, David S. Gordon, Michael S. Samlowski, Wolfram E. Kurzrock, Razelle Tannir, Nizar Friedland, David Mendelson, David S. Vogelzang, Nicholas J. Rasmussen, Erik Wu, Benjamin M. Bass, Michael B. Zhong, Zhandong D. Friberg, Gregory Appleman, Leonard J.